Collecting language, speech acoustics, and facial expression to predict psychosis and other clinical outcomes: strategies from the AMP® SCZ initiative
- Zarina R. Bilgrami
- Eduardo Castro
- et al.
- 2025
- Schizophrenia
Publications
8 results for Daniel Mathalon
Incidence, Prevalence, and Stability of Remission in Individuals With Clinical High Risk for Psychosis
- Johanna Seitz-Holland
- Grace R. Jacobs
- et al.
- 2025
- JAMA network open
Data analysis strategies for the Accelerating Medicines Partnership® Schizophrenia Program
- Nora Penzel
- Pablo Polosecki
- et al.
- 2025
- Schizophrenia
Enabling FAIR data stewardship in complex international multi-site studies: Data Operations for the Accelerating Medicines Partnership® Schizophrenia Program
- Tashrif Billah
- Kang Ik K. Cho
- et al.
- 2025
- Schizophrenia
The MR neuroimaging protocol for the Accelerating Medicines Partnership® Schizophrenia Program
- Michael P. Harms
- Kang-Ik K. Cho
- et al.
- 2025
- Schizophrenia
Cognitive assessment in the Accelerating Medicines Partnership® Schizophrenia Program: harmonization priorities and strategies in a diverse international sample
- Kelly Allott
- Walid Yassin
- et al.
- 2025
- Schizophrenia
Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ): Rationale and Study Design of the Largest Global Prospective Cohort Study of Clinical High Risk for Psychosis
- Cassandra M.J. Wannan
- Barnaby Nelson
- et al.
- 2024
- Schizophrenia Bulletin
Biclustered independent component analysis for complex biomarker and subtype identification from structural magnetic resonance images in schizophrenia
- Cota Navin Gupta
- Eduardo Castro
- et al.
- 2017
- Frontiers in Psychiatry